Breg cells were included in these cultures, and their effects were evaluated by using flow cytometry and ELISA. Results: B-cell lymphoma 6, IL-21, inducible costimulator, CXCR5, and programmed cell death protein 1 (PD-1) expressions increased on stimulated human T cells, characterizing T FH cell maturation. In cocultures they differentiated B cells into CD138 1 plasma and IgD 2 CD27
Abbreviations used
Bcl DCs and B cells at a later stage are important for the maintenance of terminal differentiation of T FH cells, 9 which highly express IL-21 receptor (IL-21R) in GCs. 10 Furthermore, interactions between T FH cells and B cells support survival and selection signals mediated through the IL-21/IL-21R and CD40/CD40 ligand axis and subsequent T FH activity inducing efficient terminal differentiation of B cells. 11 Within the follicles, regulatory mechanisms operate to prevent the emergence of autoreactivities while allowing the selection of high-affinity antibody-producing cells. The control of T FH cell development and T FH cell functions now appears to be significant for the restriction of aberrant antibody responses, 12, 13 with the possible implication of a recently described but not yet fully characterized subpopulation of T cells called follicular regulatory T (T FR ) cells.
14 Regulatory B (Breg) cells correspond to B lymphocytes that control the proportions, functions, or both of various effector cells to restrain the development of immune responses. Their depletion or defective activity skew T-cell differentiation into T H 1 and T H 17 cell subsets associated with worsened autoimmune disorders. 15, 16 After activation through CD40 and Toll-like receptor (TLR) 9, human B cells acquire regulatory activities suppressing cellular immune responses. [17] [18] [19] Whether human Breg cells can affect the humoral response has never been evaluated. We elaborated an in vitro model for the generation of functional human T FH cells and a coculture system to assess the capacity of Breg cells to influence their effect on the terminal differentiation of B cells.
The presence of Breg cells alters the development and further suppresses the functions of T FH cells, repressing the GC reactions. We conclude that impaired Breg cell controls in vivo can bring about the T FH cell-dependent restriction of humoral responses and might lead to the development of aberrant autoimmune responses.
METHODS
T and B lymphocytes were in vitro differentiated into T FH 
RESULTS

In vitro differentiation of human T FH cells
To establish our model, T cells were polyclonally stimulated with anti-CD3 and anti-CD28 antibodies in the presence of IL-12 and IL-21 (see Fig E1, Fig E2, A, in this article's Online Repository at www.jacionline.org). This induction concerned mainly the naive population (see Fig E2, B) and was specific to CD4 1 T cells (see Fig E3, A, in this article's Online Repository at www.jacionline.org), resulting in a T H 2 cytokine profile of ab 1 T cells (see Fig E3, B and C). Differentiated T FH cells were cocultured with nonstimulated B cells (see Fig E1,  A) . The frequencies of CD138 1 plasma cells and IgD
2
CD27
1 memory B cells were upregulated (see Fig E2, C) , and increased amounts of IgM, IgG, and IgA were secreted (see Fig E2, D) primarily by the memory B-cell compartment (see Fig E3, D) . These experiments demonstrate that in vitrogenerated human T FH cells acquire efficient functional properties, triggering the terminal differentiation of B cells into antibodysecreting cells.
Inhibitory effect of Breg cells on T FH cell development
To evaluate the role of Breg cells, B cells were stimulated through CD40 and TLR9, and these committed Breg cells were added at the onset of T-cell differentiation (see Fig E1, B) . Induction of T FH markers was not observed; percentages of Bcl-6
, and PD-1 1 T cells remained significantly decreased; and median fluorescence intensities of the markers were not upregulated (Fig 1, A) . In the presence of nonstimulated B cells, T FH cell maturation occurred, percentages of all markers were not affected, and differentiation into Bcl-6 high , IL-21 high , CXCR5 high , ICOS high , PD-1 high T cells occurred, as in the absence of B cells (Fig 1, B) . These findings indicate that control of T FH maturation is conducted by committed Breg cells only and is primarily directed to the naive CD4 1 T cells (Fig 1, C) . Although the frequency of CXCR5
high PD-1 high T cells is restrained by the Breg cells differentiated from both naive and memory B cells, Bcl-6 upregulation is controlled by Breg cell-committed naive B cells, suggesting that the suppressive capacity is mainly carried by the naive B cells (see Fig E4, A and B, in this article's Online Repository at www.jacionline. org). The inhibitory effect is also efficient on T FH cells differentiated from splenic CD4 1 T cells (see Fig E4, C), suggesting a general immunoregulatory mechanism. When Breg cells were added on CD4 1 differentiated T FH cells, the expression of all markers was affected slightly, and their median fluorescence intensities were not diminished (Fig 1, D) , indicating that development of fully differentiated T FH cells cannot be reversed by Breg cells.
Mechanisms of B-cell regulation on T FH cell development
Importance of cell contacts and soluble factors.
CD4
1 T cells were stimulated in the lower chamber of Transwell (Croning Inc, Corning, NY) systems (Fig E1, C) , with Breg cells added in the upper chamber (Fig 2, A) . The Breg cell-induced decreased percentages of Bcl-6 1 , ICOS
1
, and PD-1 1 T cells were not observed, whereas the downregulated percentages of IL-21
1 and, to a lesser extent, CXCR5 1 T cells persisted (Fig 2, A) . In the supernatant of Breg cells (see Fig E1,  C) , percentages of IL-21
1 and, to a lesser extent, CXCR5 1 T cells were diminished (Fig 2, B) , whereas percentages of Bcl-6 1 , ICOS 1 , and PD-1 1 T cells remained increased (Fig 2, C) . These data indicate that regulation of Bcl-6, ICOS, and PD-1 depends on cellular contacts and that soluble factors are involved in the control of IL-21 expression, whereas modulation of CXCR5 likely requires synergistic effects of soluble factors and cell-cell contacts.
The molecules involved. Beyond the previous phenotype CD40 , and CD73 2 (see Fig E5, B) . To determine the molecules involved in Breg cell control, blocking antibodies were used in cocultures (see Fig E1, D) . The expression of Bcl-6, ICOS, and PD-1 was maintained (Fig 2,  D) , indicating the participation of CD40 ligand, CD80, CD86, and ICAM in the Breg cell control. Anti-PD-L1 blocking antibody incompletely preserved the population of Bcl-6 1 T cells, suggesting that PD-1/PD-L1 interaction might be partially involved in regulating Bcl-6 expression.
The blockade of IL-10 receptor (IL-10R) or TGF-b prevented the decrease in percentages of IL-21 1 T cells, whereas CXCR5 expression was preserved only after IL-10R blocking (Fig 2, E) . Altogether, IL-10 and TGF-b are Breg cell-derived cytokines involved in the regulation of IL-21 and CXCR5 and of IL-21, respectively. (Fig 1, A) or nonstimulated B cells (Fig 1, B) . J ALLERGY CLIN IMMUNOL VOLUME 140, NUMBER 1
Suppressive activity of Breg cells on T FH cell functions
T FH cell-differentiated cells and nonstimulated B cells were cocultured for 6 days in the presence of Breg cells (see Fig E1,  E) . The T FH cell-dependent generation of CD138 1 plasma cells and IgD
2
CD27
1 memory B cells did not occur (Fig 3, A) , and the T FH cell2induced production of IgM, IgG, and IgA was inhibited (Fig 3, B) . This inhibition is directed to the immunoglobulin production induced by the T FH cells generated from naive and memory T cells (Fig 3, C) and is primarily directed to the terminal differentiation of the memory B-cell compartment (see Fig E3, D) . The suppressive capacity can be supported by Breg cells originated from both naive and memory B cells (see Fig E4, A and D) .
Mechanisms of B-cell regulation on T FH cell functions
Importance of cell contacts. T FH cells and nonstimulated B cells were cocultured in the lower chamber of the Transwell systems for 6 days, with the Breg cells in the upper chamber (see Fig E1, F) . Production of IgM, IgG, and IgA was recovered (Fig 3, B) . These results substantiate the necessity of direct cell contacts for the Breg cells to suppress the T FH cell-dependent terminal differentiation of B cells into antibody-secreting cells. These effects rely on the control of IL-21R. Its induced expression on T FH cells involved in the maintenance of their differentiation 9 and its T FH cell-dependent induction on nonstimulated B cells required for their terminal differentiation 11 were inhibited in the presence of Breg cells (Fig 4, A) . (Fig 2, B) and percentages (Fig 2, C) with Breg cells or their supernatant (spt). D and E, Percentages after coculture with blocking antibodies. *P < .05, **P < .01, and ***P < .001 (Wilcoxon test). Results are means 6 SEMs of 6 experiments.
Induction of T FR cells. The percentages of forkhead box P3 (Foxp3)
1 T cells (see Fig E1, E) within the CXCR5 1 T cells was not (Fig 4, B) . These data indicate that Breg cells specifically increase the proportion of T FR cells known to control the T FH cell-dependent humoral response. 20 T FH cells with nonstimulated B cells but also Breg cells produced TGF-b, levels of which were not increased in the cocultures (Fig 4, C) . In contrast, levels of IL-10-Breg cells were strikingly increased. By using anti-TGF-b blocking antibodies, but not anti-IL-10R blocking antibodies, the frequencies of Foxp3 1 T cells within the CXCR5
T cells were diminished (Fig 4, D) , demonstrating a role for TGF-b in induction of T FR cells. The decreased frequencies in Transwell experiments showed that cell contacts were also necessary (Fig 4, D) . Fig E6, A, in this article's Online Repository at www.jacionline.org), polyclonally stimulated to mimic antigen stimulation, and cocultured (see Fig E6, B) 1 non-T FH cells (Fig 5, A) . In the presence of Breg cells, immunoglobulin secretions were downregulated. Phenotypically in vivo-differentiated T FH cell markers slightly decreased in the presence of Breg cells (Fig 5, B) , but the percentages of positive T cells were downregulated (Fig 5, C) . Neither the phenotype nor the frequency of CXCR5 
PD-1
2 CD4 1 non-T FH cells were affected by the addition of Breg cells (Fig 5, B and C) (Fig 5, D) . All these data demonstrate that in vivo T FH cells are sensitive to the suppressive activity of Breg cells and that in vivo T FR cells are receptive to and their proportions increase in response to Breg cell signals.
DISCUSSION
We characterize cooperative functions for IL-12 and IL-21 to generate human T FH cells in vitro. These differentiated T FH cells were functional, helping human B cells to differentiate into plasma and memory B cells and allowing immunoglobulin secretion. Our study supplements the great diversity of signals that produce efficient T FH cells. [21] [22] [23] [24] [25] [26] [27] [28] Moreover, for the first time, we show that human Breg cells can develop negative effects on humoral immune responses toward control of the generation and functions of T FH cells. Stimulation with CD40 and TLR9 was a prerequisite because nonstimulated B cells that might contain in vivo-preconditioned Breg cells were unable to affect the T FH cells in cocultures. Committed Breg cells, which primarily originated from naive B cells, downregulated the T FH cell-specific markers on tonsillar and splenic differentiated (Fig 3, B) and after cocultures with T FH cells from purified naive and memory T cells (Fig 3, C) . TW, Transwell system. *P < .05, **P < .01, ***P < .001, and ****P < .0001 (Wilcoxon test). Results are means 6 SEMs of 6 experiments.
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T cells, which mainly originated from naive CD4 1 T cells. A decreased frequency using in vivo-sorted T FH cells was also observed. In the follicles maturation into T FH cells occurs in the T-cell zone and at the T-cell/B-cell border of the GCs. Hence Breg cells have the capacity to inhibit T FH cell development within secondary lymphoid tissues. CD40 plus TLR9 stimulation upregulated CXCR5 expression on the Breg cell surface (see Fig E5, C) , suggesting that Breg cells can also migrate within the GCs to control T FH cell functions. Thus Breg cells, which are derived from naive or memory B cells, inhibited the terminal 38 In mice they exert an IL-10-and TGF-b-dependent inhibitory effect on GC-located T FH cells and on the humoral B-cell response. Our study suggests a Breg cell-dependent increase in the T FR cell proportion that likely participates in the restriction of T FH terminal differentiation and functions, reducing the humoral response in human subjects, with a preponderant role ascribed to TGF-b. Transwell experiments indicate also the requirement of cellular interaction, which is consistent with the role assigned to TGF-b and cell-surface cytotoxic T lymphocyte-associated antigen 4 in regulation of the humoral response. 39 However, it is still unclear how these cells operate. T FR cells could directly act on B cells, 40 whereas Breg cells could also directly modulate T FH cell functions. These options remain to be explored.
Finally, we observed the induction of IL-21R on T FH cells and its T FH cell-mediated induction on B cells, as expected. 9, 10, 41 The Breg cell-mediated reduction arises as an additional negative feedback to regulate the T FH cell-dependent GC responses. In this context the maturation of B cells secreting IL-10 requires IL-21 and CD40. 42, 43 The high density level of IL-21R observed on Breg cells might explain their prominent sensitivity to regulate T FH cells and the associated humoral responses.
In conclusion, it has become clear that the proportion of T FH cells relative to the neighboring T FR and Breg cells will influence the balance, modulating humoral responses and tolerance achievement. It is noteworthy that abnormal functions of T FH cells cause deleterious effects and trigger autoimmunity. [44] [45] [46] [47] [48] [49] A better understanding of human T FH , T FR , and Breg cell interrelations is worthy of pursuit to elaborate new therapeutic strategies specifically in patients with autoimmune disorders in whom suppressive Breg cell functions are lacking. 
